About AiCure
What AiCure is building
Technologies used at AiCure
iOSCompany culture
Patient-first
Real-time access to patient data helps inform safety and efficacy results.
Resource Allocation
Earlier decisions about study viability and resource allocations.
Funding rounds
Total Funding
Last funding round type
Company type
AiCure news and updates
AiCure launched clinical site services offering on Sep 7th 22'.
AiCure, an artificial intelligence (AI) and advanced data analytics company focused on improving clinical trials, today announced the launch of its clinical site services offering.
Sep 7, 2022 | aicure.comAiCure hires Andre Paredes as VP of Product Operations
AiCure has hired Andre Paredes, PhD, as Director of OpenDBM Community, Sarah Kark, PhD, as Senior Digital Neuroscientist, and Sondra Pepe, as VP of Product Operations.
Jan 1, 2022 | appliedclinicaltrialsonline.comAiCure is developing precision medicine solutions on Apr 18th 22'.
Outsourcing-Pharma recently spoke with Rich Christie, chief medical officer of AI-focused solutions provider AiCure, about how AI can be used to analyze and predict patient behavior, develop precision medicine solutions, and improve both care and quality of life.
Jan 1, 2022 | outsourcing-pharma.comAiCure CEO, Ed Ikeguchi, Named Among PharmaVOICE’s Top 100 Most Inspiring People
The PharmaVOICE 100 recognizes 100 of the most inspirational, motivational, and transformational individuals throughout the life-sciences industry.
Aug 3, 2021 | aicureAiCure Improves Flexibility to Customize Dosing Support, Bolsters Leadership Team to Drive Growth
AiCure is well established for strong growth and to further empower life science organizations with data-driven insights.
Apr 27, 2021 | aicureAiCure and The IMA Group Partner to Optimize Clinical Trial Recruitment and Patient Engagement
IMA Clinical Research, a division of The IMA Group, will equip patients with AiCure’s patient engagement solution to observe health management in a non-trial setting, advancing future trial recruitment criteria
Mar 15, 2021 | aicureAiCure launched AI-powered digital biomarker platform on May 11th 20'.
FREMONT, CA: AiCure, an AI and advanced data analytics company missioned on improving clinical trials, introduces OpenDBM, an open-source type of its computer vision and AI-powered digital biomarker platform, at CNS Summit 2020.
May 10, 2020 | cioreview.com